Research & KnowledgeEvent: September 3, 2026
Windgap Medical, Inc. published a framework from Eli Lilly and Company's device and delivery science group treating subcutaneous injection as one coupled system instead of four separate problems solved independently.
Published
Signal category
Research & Knowledge
Quote
“A team from Eli Lilly and Company's device and delivery science group just published a framework that treats subcutaneous injection as one coupled system instead of four separate problems solved independently.”
— Aaron Mann|Windgap Medical, Inc. team
Company
Windgap Medical, Inc.
Injecting simplicity into complex drug delivery
- Industry
- Pharmaceutical Manufacturing
- Location
- Watertown, US
- Company size
- 20 employees
Windgap Medical offers autoinjector platforms for complex injectables, freeing patients, families and potential treatments from the limitations of current technology. Its first product is for the administration of adrenaline for anaphylaxis, with additional products under development.
Founded 2011